Zolmitriptan Impurity 13 | CAS 16851-30-2 - Request Quote
Zolmitriptan Impurity 13
| SZ CAT No: | SZ-Z004050 |
| CAS No | 16851-30-2 |
| Mol.F. | C9H21NO2 |
| Mol.Wt. | 175.3 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Zolmitriptan Impurity 13 is chemically 3,3-Diethoxy-N,N-dimethylpropan-1-amine. Zolmitriptan Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Zolmitriptan Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zolmitriptan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 16851-30-2
Purchase 16851-30-2
Order 16851-30-2
Enquire 16851-30-2
price of 16851-30-2
16851-30-2 Supplier
16851-30-2 Manufacturer
16851-30-2 Exporter
buy high quality Zolmitriptan Impurity 13
Purchase Zolmitriptan Impurity 13
Zolmitriptan Impurity 13 suppliers
Zolmitriptan Impurity 13 manufacturers
Zolmitriptan Impurity 13 price
Order Zolmitriptan Impurity 13
Enquire Zolmitriptan Impurity 13
Zolmitriptan Impurity 13 cost
Zolmitriptan Impurity 13 Supplier
Zolmitriptan Impurity 13 Distributor
Zolmitriptan Impurity 13 for Method Validation
Zolmitriptan Reference Standard
Zolmitriptan Impurity 13 for ANDA Filing
Zolmitriptan Impurity 13 for Forced Degradation Studies
Zolmitriptan Impurity 13 Identification Standards
Zolmitriptan Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


